Shopping Cart
- Remove All
- Your shopping cart is currently empty
SPR206 is a polymyxin analogue and an important class of antibiotic for the treatment of bacterial infections due to multidrug resistant Gram-negative pathogen.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
100 mg | Inquiry | Backorder | |
500 mg | Inquiry | Backorder |
Description | SPR206 is a polymyxin analogue and an important class of antibiotic for the treatment of bacterial infections due to multidrug resistant Gram-negative pathogen. |
Targets&IC50 | Pseudomonas aeruginosa Pa14:(MIC)0.125 mg/L , Acinetobacter baumannii (NCTC13301):0.125 mg/L |
In vitro | SPR206 exhibits potent antimicrobial effects against Gram-negative bacteria, displaying Minimum Inhibitory Concentration (MIC) values indicating its effectiveness: 8 mg/L for E. coli IHMA558090, 0.125 mg/L for E. coli ATCC 25922 and A. baumannii ATCC 19003, 0.125 mg/L for K. pneumoniae ATCC 13882, 0.25 mg/L for P. aeruginosa ATCC 27853, and 0.06 mg/L for A. baumannii NCTC13424. Additionally, it demonstrates reduced cytotoxicity [1]. |
In vivo | In lung tissue and in the thigh model,SPR206 (0.125-30 mg/kg; intravenous injection or subcutaneous injection; every 8 hours or every 4 hours; for 16 hours or 24 hours; neutropenic mice) treatment reduces the burden of Pa14 and NCTC13301 [2]. |
Molecular Weight | 1144.75 |
Formula | C52H82ClN15O12 |
Relative Density. | no data available |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.